BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 21517819)

  • 41. [Bone localizations of Hodgkin's disease].
    Manzini E; Romagnoli R; Di Prisco AU; Mussini C
    Radiol Med; 1976 May; 62(5):321-34. PubMed ID: 1078286
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) in serum in bone marrow transplanted patients.
    Sallerfors B; Olofsson T; Lenhoff S
    Bone Marrow Transplant; 1991 Sep; 8(3):191-5. PubMed ID: 1720339
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Squamous cell carcinoma of the urachus producing granulocyte colony-stimulating factor.
    Kuramoto T; Kikkawa K; Nishihata M; Matsumura N; Kohjimoto Y; Inagaki T; Uekado Y; Hara I
    Urology; 2009 Feb; 73(2):442.e5-7. PubMed ID: 18455774
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.
    Vose JM; Bierman PJ; Kessinger A; Coccia PF; Anderson J; Oldham FB; Epstein C; Armitage JO
    Bone Marrow Transplant; 1991 Feb; 7(2):139-43. PubMed ID: 1675592
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Granulocyte colony-stimulating factor (G-CSF) producing bladder cancer subsequently developed from recurrent non-muscle invasive bladder cancer.
    Sawazaki H; Taki Y; Takeuchi H
    Int J Urol; 2010 Aug; 17(8):741-2. PubMed ID: 20500535
    [No Abstract]   [Full Text] [Related]  

  • 46. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY; Kao A; Yen RF
    Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does granulocyte colony-stimulating factor ameliorate the proinflammatory response in human meningococcal septic shock?
    Rojahn A; Brusletto B; Øvstebø R; Haug KB; Kierulf P; Brandtzaeg P
    Crit Care Med; 2008 Sep; 36(9):2583-9. PubMed ID: 18679115
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The use of positron emission tomography with [18F] 2-fluoro-D-2-deoxyglucose (FDG-PET) in Hodgkin and non-Hodgkin's lymphoma.
    Chiusolo P; Sica S; Leone G
    Hematology; 2003 Dec; 8(6):403-8. PubMed ID: 14668036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Erythema nodosum secondary to granulocyte colony-stimulating factor in a patient with Hodgkin lymphoma during CD34+ cell mobilization for autologous peripheral blood stem cell transplantation: a dose-mediated effect.
    George S; George B; Gorak E
    Biol Blood Marrow Transplant; 2005 Oct; 11(10):816-7. PubMed ID: 16182183
    [No Abstract]   [Full Text] [Related]  

  • 50. Polyostotic form of malignant lymphogranuloma.
    Horský I; Hanecka M
    Neoplasma; 1968; 15(3):301-7. PubMed ID: 5667093
    [No Abstract]   [Full Text] [Related]  

  • 51. Gingival cancer suspected of producing granulocyte colony-stimulating factor: report of a case.
    Ishigami T; Yoshida H; Yusa H; Yanagawa T
    J Oral Maxillofac Surg; 2001 Jul; 59(7):804-8. PubMed ID: 11429746
    [No Abstract]   [Full Text] [Related]  

  • 52. [Role of FDG-PET in Staging and Therapy of Children with Hodgkin Lymphoma].
    Kluge R; Körholz D
    Klin Padiatr; 2011 Nov; 223(6):315-9. PubMed ID: 22012607
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PET-guided clinical trials in Hodgkin lymphoma: to agree or not to agree, that is the reviewer's question.
    Gallamini A; Meignan M
    Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):1-3. PubMed ID: 29026947
    [No Abstract]   [Full Text] [Related]  

  • 54. Diffuse bone marrow involvement of Hodgkin lymphoma mimics hematopoietic cytokine-mediated FDG uptake on FDG PET imaging.
    Chiang SB; Rebenstock A; Guan L; Alavi A; Zhuang H
    Clin Nucl Med; 2003 Aug; 28(8):674-6. PubMed ID: 12897658
    [TBL] [Abstract][Full Text] [Related]  

  • 55. F-18 FDG PET imaging in a patient with granulocyte colony stimulating factor producing pulmonary pleomorphic carcinoma.
    Takahashi S; Kuwabara K; Sawafuji M; Akiduki S; Ishizaka A
    Clin Nucl Med; 2008 Aug; 33(8):555-7. PubMed ID: 18645378
    [No Abstract]   [Full Text] [Related]  

  • 56. Increased bone marrow activity on F-18-FDG PET/CT in granulocyte colony stimulating factor producing anaplastic thyroid carcinoma.
    Zweifel M; Stenner-Liewen F; Weber A; Samaras P; Zaugg K; Knuth A; Soyka JD
    Clin Nucl Med; 2010 Feb; 35(2):103-4. PubMed ID: 20090458
    [No Abstract]   [Full Text] [Related]  

  • 57. [A case of gallbladder cancer producing granulocyte-colony stimulating factor and possible parathyroid hormone related protein].
    Kuroki M; Uto H; Ido A; Kuwata G; Nakama T; Ochiai T; Hori T; Hirono S; Hayashi K; Marutsuka K; Tsubouchi H
    Nihon Shokakibyo Gakkai Zasshi; 2000 Apr; 97(4):478-83. PubMed ID: 10793573
    [No Abstract]   [Full Text] [Related]  

  • 58. [A Case of Granulocyte-Colony Stimulating Factor-Producing Gastric Cancer Successfully Treated with Trastuzumab].
    Matsushita K; Takeno A; Tamura S; Taniguchi H; Ishida T; Sato Y; Morimoto Y; Kusama H; Hashimoto T; Kimura K; Katsura Y; Ohmura Y; Nitta K; Kagawa Y; Okisiro M; Sakisaka H; Egawa C; Takeda Y; Kato T
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):1968-70. PubMed ID: 26805233
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bone involvement in a patient with Hodgkin lymphoma producing granulocyte colony stimulating factor: PET imaging.
    Yoshida T; Sato K; Ozaki K; Matsuyama T; Ozawa K
    Br J Haematol; 2011 Aug; 154(4):424. PubMed ID: 21517819
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.